<DOC>
	<DOC>NCT01789606</DOC>
	<brief_summary>A self-selection and actual use trial to evaluate the extent to which consumers will appropriately select and use the 600 mg immediate release/extended release caplets and comply with dosing instructions.</brief_summary>
	<brief_title>Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>at least 12 years of age use of at least 5 doses per month of overthecounter pain relievers over the past 3 months provide written informed consent (subjects 12&lt;18 years of age provide a written assent and parent/guardian will provide written informed consent) capable of and willing to swallow the study medication participated in other research studies in the last 6 months they or someone else in their household work for a pharmaceutical company, is a relative of study site personnel involved with the study, or an immediate family member is already enrolled in the study have a history of known allergies to ibuprofen, aspirin, or other NSAIDs have a history of heart surgery in the last 60 days or planned heart surgery in the next 60 days female subjects are pregnant or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Self-selection and actual use/compliance trial.</keyword>
</DOC>